Managing Neuropsychiatric Effects of COVID-19 in Multiple Sclerosis
The researchers concluded that effective monitoring of psychiatric and cognitive comorbidities was essential for patients with MS and updated treatment options applicable to the conditions of the viral pandemic are a necessity.
